170 related articles for article (PubMed ID: 24877026)
1. Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway.
Liu YB; Gao X; Deeb D; Arbab AS; Gautam SC
J Carcinog Mutagen; 2013 Nov; Suppl 6():005. PubMed ID: 24877026
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin.
Liu YB; Gao X; Deeb D; Brigolin C; Zhang Y; Shaw J; Pindolia K; Gautam SC
Int J Oncol; 2014 Oct; 45(4):1735-41. PubMed ID: 25175770
[TBL] [Abstract][Full Text] [Related]
3. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2.
Deeb D; Gao X; Liu YB; Pindolia K; Gautam SC
Int J Oncol; 2014 May; 44(5):1707-15. PubMed ID: 24603988
[TBL] [Abstract][Full Text] [Related]
4. Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction.
Guo Y; Zhang W; Yan YY; Ma CG; Wang X; Wang C; Zhao JL
J BUON; 2013; 18(2):477-85. PubMed ID: 23818365
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells.
Byun JY; Kim MJ; Eum DY; Yoon CH; Seo WD; Park KH; Hyun JW; Lee YS; Lee JS; Yoon MY; Lee SJ
Mol Pharmacol; 2009 Oct; 76(4):734-44. PubMed ID: 19574249
[TBL] [Abstract][Full Text] [Related]
6. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.
Deeb D; Gao X; Jiang H; Janic B; Arbab AS; Rojanasakul Y; Dulchavsky SA; Gautam SC
Biochem Pharmacol; 2010 Feb; 79(3):350-60. PubMed ID: 19782051
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells.
Ling YH; Liebes L; Zou Y; Perez-Soler R
J Biol Chem; 2003 Sep; 278(36):33714-23. PubMed ID: 12821677
[TBL] [Abstract][Full Text] [Related]
8. The triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunction.
Yan YY; Bai JP; Xie Y; Yu JZ; Ma CG
Oncol Lett; 2013 Jan; 5(1):242-248. PubMed ID: 23255929
[TBL] [Abstract][Full Text] [Related]
9. Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo.
Zhao Q; Liu Y; Zhong J; Bi Y; Liu Y; Ren Z; Li X; Jia J; Yu M; Yu X
Cell Death Discov; 2019; 5():125. PubMed ID: 31396402
[TBL] [Abstract][Full Text] [Related]
10. c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.
Chaudhary P; Vishwanatha JK
Biochem Pharmacol; 2014 Oct; 91(4):457-73. PubMed ID: 25181458
[TBL] [Abstract][Full Text] [Related]
11. Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria.
Wu CC; Chan ML; Chen WY; Tsai CY; Chang FR; Wu YC
Mol Cancer Ther; 2005 Aug; 4(8):1277-85. PubMed ID: 16093444
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation.
Moungjaroen J; Nimmannit U; Callery PS; Wang L; Azad N; Lipipun V; Chanvorachote P; Rojanasakul Y
J Pharmacol Exp Ther; 2006 Dec; 319(3):1062-9. PubMed ID: 16990509
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species‑mediated mitochondrial death pathway.
Lee HH; Park C; Jeong JW; Kim MJ; Seo MJ; Kang BW; Park JU; Kim GY; Choi BT; Choi YH; Jeong YK
Int J Oncol; 2013 Mar; 42(3):1036-44. PubMed ID: 23292300
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549.
Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A
Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.
Gao X; Liu Y; Deeb D; Arbab AS; Gautam SC
J Exp Ther Oncol; 2014; 10(4):275-83. PubMed ID: 25509983
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent.
Deeb D; Gao X; Liu YB; Gautam SC
J Exp Ther Oncol; 2012; 10(1):51-64. PubMed ID: 22946344
[TBL] [Abstract][Full Text] [Related]
17. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak.
Kim YA; Xiao D; Xiao H; Powolny AA; Lew KL; Reilly ML; Zeng Y; Wang Z; Singh SV
Mol Cancer Ther; 2007 May; 6(5):1599-609. PubMed ID: 17513609
[TBL] [Abstract][Full Text] [Related]
19. Pipernonaline from Piper longum Linn. induces ROS-mediated apoptosis in human prostate cancer PC-3 cells.
Lee W; Kim KY; Yu SN; Kim SH; Chun SS; Ji JH; Yu HS; Ahn SC
Biochem Biophys Res Commun; 2013 Jan; 430(1):406-12. PubMed ID: 23159637
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
